MediPal Holdings Corporation
7459.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.34 | 0.09 | -0.42 | 0.59 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 11.19 | 15.97 | 14.79 | 9.39 |
| Quality | ||||
| ROIC | 0.95% | 1.17% | 0.73% | 1.49% |
| Gross Margin | 6.53% | 6.84% | 6.73% | 6.90% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 2.73% | 2.84% | 3.00% | 2.90% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -9.20 | -11.90 | -16.66 | -6.68 |
| Interest Coverage | 3,676.33 | 4,684.33 | 5,119.00 | 9,105.00 |
| Efficiency | ||||
| Inventory Turnover | 4.67 | 4.85 | 4.53 | 4.20 |
| Cash Conversion Cycle | -4.93 | -3.75 | 2.24 | -6.71 |